4 results
diagnosis hematology syndrome algorithm anemia anticoagulation apml cancer differentiation malignancy sjogrens vte
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis. Currently, edoxaban and rivaroxaban are the only
algorithm for the treatment ... anticoagulants (DOACs ... thrombosis; PE = pulmonary ... Anticoagulation #Management ... #Hematology #Oncology
►
 Aplastic Anemia - Overview Who? • M = F • 3 peaks: 1) Childhood 2) 15-25 years 3) >60 years What? • Aplastic anemia
index < 2 • EPO Level ... anemia Treatment ... #Anemia #oncology ... #hematology #diagnosis ... #management
Differentiation Syndrome in APML Epidemiology: • Incidence: common in APL (2-48% depending on the study) • Triggers:
Triggers: ATRA treatment ... Imaging: CXR- pulmonary ... Renal Failure Treatment ... APML #diagnosis #management ... #hematology #oncology
Sjogren's Syndrome Overview Epidemiology: • F > M: 9:1 • 5-6th Decades (can be any age) Autoimmune exocrinopathy multisystemic disease
, INC risk PE, Pulmonary ... Adenocarcinoma Treatment ... lubricants • Pharmacologic ... Sjogrens #Syndrome #Rheumatology ... #Diagnosis #Management
No results found for "Lever treatment management pulmonary rheumatology pharmacology oncology doac toxicity aplastic"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Lever #treatment #management #pulmonary #rheumatology #pharmacology #oncology #doac #toxicity #aplastic